Silo Pharma, Inc. (NASDAQ:SILO) Sees Large Decrease in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a large decrease in short interest in October. As of October 31st, there was short interest totalling 101,900 shares, a decrease of 21.2% from the October 15th total of 129,300 shares. Approximately 2.4% of the company’s stock are short sold. Based on an average daily volume of 169,300 shares, the short-interest ratio is presently 0.6 days.

Silo Pharma Trading Down 1.7 %

Shares of Silo Pharma stock traded down $0.02 on Friday, reaching $1.13. The stock had a trading volume of 221,630 shares, compared to its average volume of 143,675. The business’s 50 day moving average is $1.11 and its two-hundred day moving average is $1.39. Silo Pharma has a 1 year low of $0.84 and a 1 year high of $4.50.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.